Two Sigma Advisers’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $804K | Sell |
|
|||||
|
2023
Q4 | $504K | Buy |
|
|||||
|
2023
Q3 | $507K | Buy |
|
|||||
|
2023
Q2 | $952K | Sell |
|
|||||
|
2023
Q1 | $1.5M | Buy |
|
|||||
|
2022
Q4 | $1.65M | Buy |
|
|||||
|
2022
Q3 | $3.75M | Buy |
|
|||||
|
2022
Q2 | $2.53M | Buy |
|
|||||
|
2022
Q1 | $2.96M | Sell |
|
|||||
|
2021
Q4 | $4.72M | Buy |
|
|||||
|
2021
Q3 | $3.48M | Buy |
|
|||||
|
2021
Q2 | $674K | Buy |
|
|||||
|
2021
Q1 | $788K | Buy |
|